Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate, umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospects

Maintenance pharmacological treatment for stable chronic obstructive pulmonary disease (COPD) is based on inhaled drugs, including long-acting muscarinic receptor antagonists (LAMA), long-acting β(2)-adrenoceptor agonists (LABA) and inhaled corticosteroids (ICS). Inhaled pharmacological treatment ca...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ther Adv Respir Dis
Egile Nagusiak: Malerba, Mario, Nardin, Matteo, Santini, Giuseppe, Mores, Nadia, Radaeli, Alessandro, Montuschi, Paolo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2018
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5941662/
https://ncbi.nlm.nih.gov/pubmed/29537340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753466618760779
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak